Results 141 to 150 of about 1,044,683 (223)

Nanoparticle albumin-bound paclitaxel -induced severe interstitial lung disease in a gastric cancer patient: a case report. [PDF]

Front Oncol
Liu B, Wei K, Dong J, Zhou X.
europepmc   +1 more source

Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial. [PDF]

Drug Des Devel Ther
Zhang J, Zhao K, Zhou W, Jiang G, Ding Y, Zhang Y, Dong X, Hong D, Liu X.   +8 more
europepmc   +1 more source

Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas

Oncotarget, 2021
Gould, Andrew, Zhang, Daniel, Arrieta, Víctor A., Stupp, Roger, Sonabend, Adam M.   +4 more
openaire   +2 more sources

Nanoparticle Albumin-Bound Paclitaxel and Nivolumab for PD-1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma. [PDF]

Cancer Med
Adkins D, Ley JC, Auberle C, Knapp B, Zaretsky J, Liu J, Oppelt P.   +6 more
europepmc   +1 more source

Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers. [PDF]

World J Surg Oncol
Wang X, Zha Y, Li P, Fu S, Xu L, Jiang W, Wu J, Mao Y.   +7 more
europepmc   +1 more source

Efficacy and safety of albumin-bound paclitaxel combined with anlotinib and immunotherapy in advanced non-small cell lung cancer with liver metastases: a retrospective study. [PDF]

BMC Cancer
Teng H, Qin N, Liu K, Gong C, Tang J, Li X.   +5 more
europepmc   +1 more source

Albumin-bound paclitaxel drives a cytotoxic CD8⁺ T cell enriched immune microenvironment in triple negative breast cancer. [PDF]

Front Immunol
Luo D, Jin X, Zhang S, Zeng X, Zhang S, Li D, Xiong W, Luo Y, Hu Z, Long J, Zeng Z.   +10 more
europepmc   +1 more source

Efficacy and safety of albumin-bound paclitaxel combined with simvastatin in the second-line treatment of small cell lung cancer: a phase II randomized controlled trial. [PDF]

BMC Med
Guan M, Zhao W, Zhang W, Chen X, Huang R, Liu X, Li Y, Wang H, Zhao L, Xu K, Ye L, Chen Z, Liu Y, Zhang Q, Ji H, He Y.   +15 more
europepmc   +1 more source

Factors associated with peripheral neuropathy development during gemcitabine plus albumin-bound paclitaxel therapy as first-line treatment for unresectable pancreatic cancer: a retrospective evaluation. [PDF]

J Pharm Health Care Sci
Ban T, Miura M.
europepmc   +1 more source

Retrospective analysis of nanoparticle albumin-bound paclitaxel combined with toripalimab and platinum as first-line treatment for Chinese patients with recurrent or metastatic head and neck cancer. [PDF]

Front Oncol
Li J, Zhong R, Yang S, He Y, Wang W, Chen P.   +5 more
europepmc   +1 more source